Not checked for notices yet.

Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma

Nusrat Jahan, Hammad Talat, Andrea Alonso and 2 more (opens in a new tab)

OncoImmunology · 2019

doi:10.1080/2162402x.2019.1577108 (opens in a new tab)

Cited by papers we hold 2

Immunotherapy for glioblastoma: the promise of combination strategies · 2022
No notice
FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.